S. Ingram and Associates, LLC.

EXECUTIVE SUMMARY: DR. SYBIL INGRAM, MBA, PH.D., CISM, CDPSE, C/CISO Dr. Sybil Ingram is a distinguished governance, risk, and compliance executive with extensive expertise in cybersecurity, data privacy, and quality management systems across multiple industries. With over twenty years of professional experience, she has established herself as one of the nation's foremost authorities on HIPAA regulations, AI ethics, and regulatory compliance frameworks. As the current Chief Compliance Officer (Fractional) at iHealthSync, Dr. Ingram spearheads the establishment of comprehensive Governance, Risk Management, and Compliance (GRC) strategies while demonstrating exceptional process optimization and stakeholder management. Her expertise in risk assessment methodologies has proven invaluable in mitigating potential risks and ensuring regulatory compliance across complex technological environments, including cloud security and AI integration. Dr. Ingram has delivered critical compliance initiatives for leading organizations including Amgen, Boston Scientific, and the Centers for Disease Control and Prevention. Her notable achievements include establishing FDA 21 CFR 820 risk management programs, leading international InfoSec audits, developing integrated FDA/ISO Quality Management Systems, and creating comprehensive HIPAA compliance frameworks. Throughout her distinguished career, Dr. Ingram has demonstrated innovative thinking through her work with emerging technologies including quantum technology security assessments. Her adaptability is evidenced by her success leading engagements across diverse international regulatory environments while maintaining unwavering compliance standards. As a recognized subject matter expert, Dr. Ingram has contributed thought leadership through publications on cybersecurity for medical devices and delivered executive presentations on critical regulatory issues.